Search research articles
Contact Us
Filters
Showing results (101-110 of 301) with videos related to
Page
of 31
Sort By:
Journal of Immunogenetics
|
April 1, 1977
Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma
G Invernizzi, G Carbone, A Meschini, et al.
Journal of the National Cancer Institute
|
November 1, 1978
Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma
G Parmiani, A Meschini, G Invernizzi, et al.
Neurosurgery
|
June 1, 1994
Successful adoptive immunotherapy with lymphokine-activated killer cells in the treatment of medulloblastoma disseminated via cerebrospinal fluid: case report
A Silvani, A Salmaggi, G Parmiani, et al.
British Journal of Cancer
|
June 1, 1971
Immunodepression during urethane and N-nitrosomethylurea leukaemogenesis in mice
G Parmiani, M I Colnaghi, G Della Porta
Human Immunology
|
June 1, 1990
Multiple VLA antigens on a subset of melanoma clones
A Anichini, R Mortarini, E Berti, et al.
International Journal of Cancer
|
January 15, 1978
In vitro and in vivo expression of original and foreign H-2 antigens and of the tumor-associated transplantation antigen of a murine fibrosarcoma
G Carbone, G Invernizzi, A Meschini, et al.
British Journal of Cancer
|
August 1, 1986
In vivo characterization of a doxorubicin resistant B16 melanoma cell line
F Formelli, C Rossi, R Supino, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1989
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction
A Anichini, A Mazzocchi, G Fossati, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experimental metastases model
M Rodolfo, C Salvi, C Bassi, et al.
Cancer Immunology, Immunotherapy : CII
|
April 24, 2001
A listing of human tumor antigens recognized by T cells
N Renkvist, C Castelli, P F Robbins, et al.
Page
of 31
Search research articles
Search
Showing results (101-110 of 301) with videos related to
Sort By:
Page
of 31
Journal of Immunogenetics
|
April 1, 1977
Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma
G Invernizzi, G Carbone, A Meschini, et al.
Journal of the National Cancer Institute
|
November 1, 1978
Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma
G Parmiani, A Meschini, G Invernizzi, et al.
Neurosurgery
|
June 1, 1994
Successful adoptive immunotherapy with lymphokine-activated killer cells in the treatment of medulloblastoma disseminated via cerebrospinal fluid: case report
A Silvani, A Salmaggi, G Parmiani, et al.
British Journal of Cancer
|
June 1, 1971
Immunodepression during urethane and N-nitrosomethylurea leukaemogenesis in mice
G Parmiani, M I Colnaghi, G Della Porta
Human Immunology
|
June 1, 1990
Multiple VLA antigens on a subset of melanoma clones
A Anichini, R Mortarini, E Berti, et al.
International Journal of Cancer
|
January 15, 1978
In vitro and in vivo expression of original and foreign H-2 antigens and of the tumor-associated transplantation antigen of a murine fibrosarcoma
G Carbone, G Invernizzi, A Meschini, et al.
British Journal of Cancer
|
August 1, 1986
In vivo characterization of a doxorubicin resistant B16 melanoma cell line
F Formelli, C Rossi, R Supino, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1989
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction
A Anichini, A Mazzocchi, G Fossati, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1990
Adoptive immunotherapy of a mouse colon carcinoma with recombinant interleukin-2 alone or combined with lymphokine-activated killer cells or tumor-immune lymphocytes. Survival benefit of adjuvant post-surgical treatments and comparison with experimental metastases model
M Rodolfo, C Salvi, C Bassi, et al.
Cancer Immunology, Immunotherapy : CII
|
April 24, 2001
A listing of human tumor antigens recognized by T cells
N Renkvist, C Castelli, P F Robbins, et al.
Page
of 31